Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2VM5

HUMAN BIR2 DOMAIN OF BACULOVIRAL INHIBITOR OF APOPTOSIS REPEAT- CONTAINING 1 (BIRC1)

Summary for 2VM5
Entry DOI10.2210/pdb2vm5/pdb
DescriptorBACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 1, ZINC ION, GLYCEROL, ... (4 entities in total)
Functional Keywordsapoptosis
Biological sourceHOMO SAPIENS (HUMAN)
Total number of polymer chains1
Total formula weight12533.56
Authors
Primary citationHerman, M.D.,Moche, M.,Flodin, S.,Welin, M.,Tresaugues, L.,Johansson, I.,Nilsson, M.E.,Nordlund, P.,Nyman, T.
Structures of Bir Domains from Human Naip and Ciap2.
Acta Crystallogr.,Sect.F, 65:1091-, 2009
Cited by
PubMed Abstract: The inhibitor of apoptosis (IAP) family of proteins contains key modulators of apoptosis and inflammation that interact with caspases through baculovirus IAP-repeat (BIR) domains. Overexpression of IAP proteins frequently occurs in cancer cells, thus counteracting the activated apoptotic program. The IAP proteins have therefore emerged as promising targets for cancer therapy. In this work, X-ray crystallography was used to determine the first structures of BIR domains from human NAIP and cIAP2. Both structures harbour an N-terminal tetrapeptide in the conserved peptide-binding groove. The structures reveal that these two proteins bind the tetrapeptides in a similar mode as do other BIR domains. Detailed interactions are described for the P1'-P4' side chains of the peptide, providing a structural basis for peptide-specific recognition. An arginine side chain in the P3' position reveals favourable interactions with its hydrophobic moiety in the binding pocket, while hydrophobic residues in the P2' and P4' pockets make similar interactions to those seen in other BIR domain-peptide complexes. The structures also reveal how a serine in the P1' position is accommodated in the binding pockets of NAIP and cIAP2. In addition to shedding light on the specificity determinants of these two proteins, the structures should now also provide a framework for future structure-based work targeting these proteins.
PubMed: 19923725
DOI: 10.1107/S1744309109038597
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon